Abstract: Abstract: The present invention relates to a Lactobacillus rhamnosus strain. In particular, the present invention relates to a composition comprising a Lactobacillus rhamnosus optionally in combination with a further lactobacilli and the use of the same in the treatment, prevention or alleviation of candidiasis.

Abstract: The present invention relates to a Lactobacillus curvatus strain. In particular, the present invention relates to a composition comprising a Lactobacillus curvatus strain in combination with a further Lactobacillus and the use of the same in the treatment of inflammatory conditions in the oral cavity.

Abstract: The present invention relates to a Lactobacillus curvatus strain. In particular, the present invention relates to a composition comprising a Lactobacillus curvatus strain in combination with a further Lactobacillus and the use of the same in the treatment of inflammatory conditions in the oral cavity.

Abstract: Novel Lactobacilli strains, Lactobacillus acidophilus strain Lba EB01 (Lba EB01), Lactobacillus paracasei strain Lbp PB01 (Lbp PB01), Lactobacillus acidophilus strain Lba EB02, Lactobacillus plantarum strain Lbpl PB02, Lactobacillus stain Lbxx EB03 and Lactobacillus strain Lbxx PB03, and strains with essentially the same advantageous properties which alone or in combination can be used as probiotics or together with a prebiotic as a synbiotic. The invention also relates to pharmaceutical compositions, dairy products, functional foods, nutraceutical and products for personal care comprising the strains alone or in combination, as well as use of the strain for prevention or treatment of vaginal infections, urogenital infections and gastrointestinal diseases.

Abstract: Novel Lactobacilli strains, Lactobacillus acidophilus strain Lba EB01 (Lba EB01), Lactobacillus paracasei strain Lbp PB01 (Lbp, PB01), Lactobacillus acidophilus strain Lba EB02, Lactobacillus plantarum strain Lbpl PB02, Lactobacillus strain Lbxx EB03 and Lactobacillus strain Lbxx PB03, and strains with essentially the same advantageous properties which alone or in combination can be used as probiotics or together with a prebiotic as a synbiotic. The invention also relates to pharmaceutical compositions, dairy products, functional foods, nutraceutical and products for personal care comprising the strains alone or in combination, as well as use of the strain for prevention or treatment of vaginal infections, urogenital infections and gastrointestinal diseases.

Abstract: A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles dispersed in an aqueous solution of a binding agent of locust bean, gum, gelatine, vegetable hydrocolloids and/or animal protein.

Abstract: A disinfecting composition includes about 0.01 to 2% by weight 2,4-dichlorobenzyl alcohol, about 0.1 to 10% by weight of glycerylmonolaurate, and about 95 to 99.5 % by weight vehicle such as a mixture of water and alcohol.